Treatment of In-Stent Restenosis With Bioresorbable Vascular Scaffolds: Optical Coherence Tomography Insights

Canadian Journal of Cardiology

Volumn 31, Issue 3, 2015, Pages 255-259

  Rivero, Fernando ^a   Bastante, Teresa ^a   Cuesta, Javier ^a   Benedicto, Amparo ^a   Restrepo, Jorge A ^a   Alfonso, Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; BARE METAL STENT; BIORESORBABLE SCAFFOLD; BIORESORBABLE VASCULAR SCAFFOLD; BIORESORBABLE VASCULAR STENT; CLINICAL ARTICLE; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STENT MALAPPOSITION; STENT THROMBOSIS; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; CORONARY RESTENOSIS; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; PROSTHESIS; PROSTHESIS FAILURE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TISSUE SCAFFOLD; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VERY ELDERLY;

ABSORBABLE IMPLANTS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84924065176     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.11.017     Document Type: Article

References (13)

1. Alfonso F., Byrne R.A., Rivero F., Kastrati A. Current treatment of in-stent restenosis. JAm Coll Cardiol 2014, 63:2659-2673.
2. Gonzalo N., Serruys P.W., Okamura T., et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009, 158:284-293.
3. Tanaka N., Terashima M., Rathore S., et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. JACC Cardiovasc Interv 2010, 3:1074-1079.
4. Grasso C., Attizzani G.F., Patané M., et al. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography. Int J Cardiol 2013, 168:4490-4491.
5. Ielasi A., Latib A., Naganuma T., et al. Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis. Int J Cardiol 2014, 173:513-514.
6. Prati F., Guagliumi G., Mintz G.S., et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012, 33:2513-2520.
7. Dörr O, Liebetrau C, Wiebe J, etal. Bioresorbable scaffolds for the treatment of in-stent restenosis. Heart Vessels 2014 Jan 4. [Epub ahead of print].
8. Naganuma T., Costopoulos C., Latib A., Sato K., Miyazaki T., Colombo A. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. JACC Cardiovasc Interv 2014, 7:e45-e46.
9. Serruys P.W., Ormiston J.A., Onuma Y., et al. Abioabsorbable everolimus-eluting coronary stentsystem (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009, 373:897-910.
10. Alfonso F., Dutary J., Paulo M., et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart 2012, 98:1213-1220.
11. Alfonso F., García J., Pérez-Vizcayno M.J., et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries. JAm Coll Cardiol 2009, 54:1036-1038.
12. Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014, 35:2541-2619.
13. Nakazawa G., Otsuka F., Nakano M., et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. JAm Coll Cardiol 2011, 57:1314-1322.